Stokes Capital Advisors, LLC Merck & Co., Inc. Transaction History

Stokes Capital Advisors, LLC

$382 Million
Q3 2024

A detailed history of Stokes Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Stokes Capital Advisors, LLC holds 42,753 shares of MRK stock, worth $4.12 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

42,753

Previous 39,206 9.05%

Holding current value

$4.12 Million

Previous $4.85 Million 0.04%

% of portfolio

1.27%

Previous 1.37%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$111.15 - $128.97 $394,249 - $457,456	3,547 Added 9.05%	42,753 $4.86 Million
Q2 2024 Jul 19, 2024	BUY	$123.8 - $132.96 $787,368 - $845,625	6,360 Added 19.36%	39,206 $4.85 Million
Q1 2024 Apr 15, 2024	BUY	$113.24 - $131.95 $137,020 - $159,659	1,210 Added 3.82%	32,846 $4.33 Million
Q4 2023 Jan 12, 2024	BUY	$100.18 - $109.02 $36,465 - $39,683	364 Added 1.16%	31,636 $3.45 Million
Q3 2023 Oct 10, 2023	SELL	$102.95 - $114.33 $2,676 - $2,972	-26 Reduced 0.08%	31,272 $3.22 Million
Q2 2023 Jul 11, 2023	SELL	$108.61 - $118.38 $151,728 - $165,376	-1,397 Reduced 4.27%	31,298 $3.61 Million
Q1 2023 Apr 12, 2023	SELL	$102.94 - $114.86 $72,366 - $80,746	-703 Reduced 2.1%	32,695 $3.48 Million
Q4 2022 Jan 18, 2023	SELL	$87.44 - $112.11 $251,564 - $322,540	-2,877 Reduced 7.93%	33,398 $0
Q3 2022 Oct 12, 2022	SELL	$84.53 - $94.96 $1.16 Million - $1.3 Million	-13,718 Reduced 27.44%	36,275 $3.12 Million
Q2 2022 Jul 13, 2022	SELL	$83.49 - $94.64 $135,086 - $153,127	-1,618 Reduced 3.13%	49,993 $4.56 Million
Q1 2022 May 10, 2022	BUY	$73.51 - $82.4 $217,883 - $244,233	2,964 Added 6.09%	51,611 $4.24 Million
Q4 2021 Jan 31, 2022	SELL	$72.28 - $90.54 $68,304 - $85,560	-945 Reduced 1.91%	48,647 $3.73 Million
Q3 2021 Oct 20, 2021	SELL	$71.68 - $78.83 $55,838 - $61,408	-779 Reduced 1.55%	49,592 $3.73 Million
Q2 2021 Jul 14, 2021	BUY	$70.31 - $77.77 $130,635 - $144,496	1,858 Added 3.83%	50,371 $3.92 Million
Q1 2021 Apr 19, 2021	BUY	$68.86 - $81.11 $272,341 - $320,790	3,955 Added 8.88%	48,513 $3.74 Million
Q4 2020 Jan 19, 2021	BUY	$71.77 - $79.65 $262,606 - $291,439	3,659 Added 8.95%	44,558 $3.65 Million
Q3 2020 Oct 16, 2020	BUY	$73.18 - $82.95 $221,662 - $251,255	3,029 Added 8.0%	40,899 $3.39 Million
Q2 2020 Jul 15, 2020	BUY	$70.42 - $80.13 $2.67 Million - $3.03 Million	37,870 New	37,870 $2.93 Million

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Capital Advisors, LLC with notifications on news.

Account

Stokes Capital Advisors, LLC Merck & Co., Inc. Transaction History